Science topics: MedicineEpidemiology
Science topic
Epidemiology - Science topic
Explore the latest questions and answers in Epidemiology, and find Epidemiology experts.
Questions related to Epidemiology
My question is oriented for customizing clinical guidelines for developing countries. On this matter, I would like to know what steps and criteria are necessary, besides a comprehensive epidemiological analysis to create and approve customized clinical guidelines and protocols in developing countries, especially when international clinical practice guidelines do not align with the local epidemiological profile and population diversity?
Suppose that in January 1996, 1000 adult residents of a community accepted an invitation to be examined for hypothyroidism at a local clinic. Eight persons were found to have the disease, it was newly discovered in 3, and 5 were already under treatment. The same group was examined again in January 1998. Six new cases of hypothyroidism were discovered; of these, two had developed symptoms several months before and had been diagnosed and treated by their personal physicians. It was learned that of the 8 hypothyroid persons discovered at the 1996 examination, one had discontinued medication and died of heart disease in 1997. Otherwise, all persons examined in 1996 came to the second examination.
Using the above information, respond to the following questions – don’t forget to use the formulas already provided in this chapter:
- What was the prevalence of hypothyroidism, treated or, not, in the examined group in January 1996? In January 1998?
- What was the annual incidence of hypothyroidism in the group?
- What was the 2-year period prevalence of hypothyroidism?
- What was the case fatality rate of hypothyroidism?
- Of all cases detected at the two examinations; what proportion was newly discovered?
- If only 900 of the original 1000 persons were still living in the community and came to the examination in January 1998, would any of your answers to the questions above be changed? If so, how?
I would greatly appreciate your assistance in verifying my calculations and providing any insights you may have.
A revolutionary phenotype is another species being delegated to reproducing its maker's kind. Then the delegated reproducer MAY eventually overthrow their before mentioned creator. Examples MAY be RNA overthrowing their maker proteins. Then DNA overthrowing their maker RNA. We avoid them by NOT delegating our reproduction to another species ,and or machine, and, more generally, using the precautionary principle. Simpler surgeries are less risky than the more complex ones.
What is the difference between limitation in recall and recall bias?
in the descriptive table, how would you interpret the p-values of the descriptives of your sample?
For instance, if there was a p < .001 between three levels of poverty, how would this be interpreted if the outcome was hypertension. There were significant differences in hypertension among the three levels of poverty?
I would greatly appreciate if you could give a better example so I can understand the idea of p-values in table 1.
(STATA)
Hello everybody.
I would like to build a Forest Plot graph that includes all this information from the table. I am unable to build the commands to include this information in the chart. I've tried to make other posts here, but I haven't been successful. Can someone help me?
I send the result of table for the chat.
I would like to set up the graph like this example:
As a dedicated researcher and professional in the field of mental and public health, I am enthusiastically seeking opportunities to pursue a Doctorate degree in various disciplines. My interests lie in the fields of Public Health, Health Policy, Healthcare Systems, Epidemiology, Population Health, Global Health, Health Promotion, Mental Health, Neuroscience, Addiction, Neuroscience, Aging and Psychiatry & Psychology. I am eager to contribute to the advancement of knowledge and make a meaningful impact in these fields through my doctoral studies.
As an international student, I am writing to inquire about the availability of PhD programs in public health at your esteemed university for the 2024 intake. As an aspiring public health professional, I am eager to pursue my academic goals at a renowned institution like yours.
I would be grateful if you could provide me with the following information:
- Program details, research areas, and deadlines
- Scholarships and financial aid availability
- Application process and link
- Admissions requirements and deadlines
- Current projects and faculty research
- Any recent program advertisements
Additionally, I would appreciate any updates or resources that you may have regarding the program's current status, faculty, and research activities.
I am wondering which term is more appropriate for use in titles when discussing a group within a larger category: 'among' or 'in'?
For example:
'Prevalence of sleep disorders among children with autism'
'Prevalence of sleep disorders in children with autism'
Could you explain the difference between using 'among' and 'in' in such contexts and advise which option is more suitable for title usage?
I have a few questions regarding that topic:
1. What technologies, both existing and in development, can enhance early detection or improve monitoring of disease spread?
2. What are all the possible environmental impacts that could be relevant to the issue?
3. What social, health, and economic impacts are pertinent to the issue?
Thank a lot,
Itay
If one biological male repopulated the Earth with 5 billion birthing people, what diseases could spread? How?
How to interpret negative total and direct effects and positive indirect effect? all are significant in mediation analysis
X --- M --- Y
Total Effect: Negative (-0.42)
Indirect Effect 1: Positive (0.03)
Indirect Effect 2: negative (-0.22)
Indirect Effect 3: positive (0.06) - Not significant
Direct Effect: Negative (-0.29)
How can I interpret these two examples below in the mediation analysis? Help me
1) with negative indirect and total effect, positive direct effect
Healthy pattern (X)
Sodium Consumption (M)
Gastric Cancer (Y)
Total Effect: Negative (-0.29)
Indirect Effect: Negative (-0.44)
Direct Effect: Positive (0.14)
Mediation percentage: 100%
2) With total and direct negative effect, positive indirect effect
Healthy pattern (x)
Sugar consumption (m)
Gastric Cancer (Y)
Total Effect: Negative (-0.42)
Indirect Effect: Positive (0.03)
Direct Effect: Negative (-0.29)
Mediation percentage: 10.3%
I would like to hire a statistician to analyze epidemiological data: calculate odds ratios, chi-squares, perform regressions and advise on whether there are other analyses that can be done with the data. Can you recommend someone?
How often does inbreeding correlate positively with eugenics? Why? My answer: Maybe not often because the last derivative population(Europeans) is not the most inbreed.
Sources
Khlat M, Khoury M. Inbreeding and diseases: demographic, genetic, and epidemiologic perspectives. Epidemiol Rev. 1991;13:28-41. doi: 10.1093/oxfordjournals.epirev.a036072. PMID: 1765114. “PIP: The demographic and quantitative genetic aspects of consanguineous marriages are reviewed before epidemiologic principles are applied to the hundreds of studies reviewed, and 3 in particular. Consanguineous unions range from cousin-cousin to more distant relatedness, and their prevalence varies by culture. Prevalence is highest in Arab countries, followed by India, Japan, Brazil and Israel. They are most common in lower educational and socioeconomic groups, the traditionally religious, and the early married, but are declining with modernization”(Khlat 1991).
There are many benefits to vaccinating the population against HPV, such as reducing the incidence of CIN2+ related to vaccine genotypes. And those who receive the HPV vaccine will experience an advantage in the transformation of HPV genotypes. How will this HPV-related epidemiological feature change in the future? Perhaps it is related to the original HPV prevalence characteristics of the population in that region.
Evaluate and interpret the existing epidemiological evidence on the relationship between millet consumption and diabetes mellitus. Summarize key findings from relevant studies, distinguish between different types of millets, and discuss the strength of evidence supporting the potential of millets in diabetes prevention.
Epidemiology of infectious diseases?
Since Titmus and Esping-Andersen, we have always categorized three types of welfare regimes among developed countries. Could we expand this to Asian, Afrian and Latin-america countries? Would such continents have any kind of welfare?
Does anyone know how to run Mediation analysis in SPSS version 25 software????
My research is a case-control study, the exposure being: dietary pattern; outcome: gastric cancer; mediator: energy (kcal).
When you read an epidemiological research paper what are some of the red flags you encounter in phrasing, statistical tests used, and glossing over controlling for confounding? For example, when you evaluate the COVID reports or vaccine research what are key elements that if not present call into question the research or if included raise doubts?
Dear ResearchGate Community,
I am currently working on a research paper titled "A Metamathematical Approach to the Susceptible-Infected-Recovered (SIR) Model: The Case of the Hong Kong Flu in New York City". The study aims to explore the application of metamathematical methods to the SIR model, with a specific focus on the Hong Kong Flu outbreak in New York City.
The research will involve a comprehensive analysis of historical epidemiological data, the development of advanced mathematical models, and the application of these models to understand the dynamics of the Hong Kong Flu outbreak. The goal is to provide a deeper understanding of the outbreak's dynamics and potentially contribute to the development of more effective strategies for managing similar outbreaks in the future.
I am reaching out to the ResearchGate community to seek potential collaborators who have expertise in the following areas:
- Metamathematics and its application to epidemiological modeling.
- The SIR model and its variants.
- Historical epidemiology, particularly related to the Hong Kong Flu.
- Public health policy and its intersection with mathematical modeling.
If you are interested in contributing to this research or know someone who might be, please feel free to reach out. I am open to collaboration with researchers at all stages of their careers, from graduate students to seasoned professionals.
I believe that this research could significantly contribute to our understanding of disease dynamics and the role of mathematical modeling in public health. I look forward to hearing from interested parties and discussing a potential collaboration.
Best regards,
Athanasios Paraskevopoulos
MSc student in Mathematics
I'm Sherif M Hammad, a student in the 4th year of the faculty of medicine Beni-Suef University, highly interested in medical research, especially Public health & epidemiology.
I'm looking forward to participating in feuter primary research or even meta-analysis as I have essential experience with data analysis (python-pandas-excel).
I also have an *idea for a Cross-sectional study but I cannot develop it into a published paper due to lack of research experience.
HOPEFULLY, I want to start my research journey with someone who has experience in clinical research
*idea=Social state and antibiotic misuse
My regards.
Sherif.
I am looking for good references for conducting causal mediation analysis using time-to-event data. If you are aware of available code (SAS, specifically), that would be very helpful as well.
I am currently completing the synthesis for a systematic review on the impact of the use of wireless devices and mental health. The systematic review looks at quantitative studies only. Due to the heterogeneity of outcomes (depression, anxiety, externalizing behaviours etc) and study designs - we have decided not to run a meta-analysis, nor we will produce forest plots. However, I feel that a harvest plot would be an attractive and intelligible method of summarizing our findings, and would complement a narrative sythesis. See below for what I mean by a harvest plot
Here is a great example of what I am trying to produce:
I am very familiar with using R / Python for data visualisation purposes, but I am initially stumped about how I might produce an attractive and aesthetically pleasing plot, short of stodgily moving rectangles around in a word / publisher doc. Can anyone suggest a package / software / website / any method that help me?
Much much much appreciation if you can!
We need to check the confounding effect and effect modifier when we are trying to finalize our model selection. So sometimes literature review can give us some ideas about the confounded effect and effect modifier while working certain topic. It we find the effect modifier then we need to do certain analysis and present the results in certain ways. If we find the confounding then we need to present the analysis differently compared to effect modifier.
What is the likelihood of another pandemic in the future as estimated by the predictive analyses carried out, based on computerised, multi-faceted, big data mathematical modelling?
To what extent does climate change, progressive global warming, climate change across continents, increased environmental pollution and the impact of toxic waste pollution on human health, etc. increase the likelihood of another pandemic in the future as estimated by the predictive analyses carried out, based on computerised, multi-faceted, big data mathematical modelling?
On 4 May 2023, the World Health Organisation lifted the state of global epidemiological emergency associated with Covid-19. The WHO declared that Covid-19 no longer posed a public health, human health threat on a global scale. The WHO introduced the state on 30 January 2020, and after more than three years, the state was lifted. But the key point is that it was lifted as an epidemiological risk 'only' on a global scale and not as a direct recommendation for individual countries. Well, in individual countries, the levels of infection and mortality, although significantly lower than in 2020, are still occurring as part of local, successive, seasonal increases in infection with specific types of relentlessly emerging successive virus strains, and are significantly different in terms of the comparative analyses carried out. Globally, almost 7 million people have died according to Covid-19 death statistics and in more than 90 per cent of cases in combination with the presence of various co-morbidities. In Poland, these deaths were 120 000 with 5.5 million diagnosed infections and more than 250 000 excess deaths. In Poland, the Covid-19 epidemiological emergency is due to be lifted at the end of June 2023. In relation to this, is there still research being conducted by the WHO on the secondary effects of the Covid-19 pandemic? The 2018 Spanish flu was an avian flu that passed to humans. This was not the only such case in which a virus that causes disease in specific animal species started to infect and cause specific diseases in humans as well. It may have been similar with the SARS-CoV-2 (Covid-19) coronavirus, because before it started infecting humans it had previously developed in certain bat species, among others. It is likely that this virus acquired new features after the modification of its genome applied in laboratories, its effect was enhanced, it escaped from the laboratory and also started infecting humans. According to mathematical models of forecasting, which take into account population growth, increased population density in urban areas, low levels of sanitation in many parts of the world, low levels of availability of clean water in many economically poorer countries, the rate of creation of new strains of influenza viruses, coronaviruses, RSV, etc., which attack humans and certain animal species, the progressive process of global warming, climate change on different continents, increased environmental pollution and the impact of toxic waste pollution on human health, etc., it is likely that the virus will become more widespread in the future.
In view of the above, I address the following question to the esteemed community of scientists and researchers:
To what extent does climate change, the progressive process of global warming, climate change across continents, the increase in environmental pollution and the impact of toxic waste pollution on human health, etc., increase the probability of the appearance of another pandemic in the future as estimated by the predictive analyses carried out based on computerised, multifaceted, data-intensive mathematical modelling?
What is the likelihood of another future pandemic estimated from ongoing predictive analytical work based on computerised multi-faceted mathematical modelling with big data?
What is the likelihood of another pandemic occurring in the future?
What do you think about this topic?
What is your opinion on this subject?
Please respond,
I invite you all to discuss,
Thank you very much,
Best wishes,
Dariusz Prokopowicz
What fundamental concerns need to be kept in mind when we compute research analysis in the fields of Statistics, Biostatistics, and Epidemiology? Will we consider only significant variable for our model building? Will we think about the biological factors, whether it is substantial or not ? Is it necessary to check the assumptions for different models as some papers do not mention them? Were interaction terms always essential to check?
Dear all,
It is well known that matching can increase the statistical power of the study if the matching variable is a strong confounder that is strongly related to both 1) exposure and 2) outcome. So, as expected, no statistical power is gained if the matching variable is a weak confounder.
In detail, 1) if the matching variable is slightly or not related to exposure, but is strongly related to the outcome, very small statistical power is gained. While, 2) if the matching variable is slightly or not related to the outcome, but is strongly related to the exposure, statistical power may even be reduced.
I do not know the reason for the last sentence. According to the articles "https://doi.org/10.1093/biomet/68.3.577" and "https://doi.org/10.1093/oxfordjournals.aje.a113475", I have made a series of assumptions; however, I need some further clarification.
I would be grateful if you kindly let me know your opinions.
Kind regards,
Recently, I found some parasitic eggs in a patient's urine sample and the patient is taking immunosuppressive drugs for SLE.
When a microscopic examination of the urine found the parasitic eggs and I think it is schistosome eggs and not Entrobiasis infections but the epidemiological conditions, it is impossible to Schistosome eggs.
I kept the sample in 70% ethanol.
How to confirm further investigation and what are the possible parasitic infection?
The development of AI models such as ChatGPT and what will happen later in the field of epidemiology.
-----------
The following is the answer from ChatGPT:
As an AI language model, I can assist you in various ways in the field of epidemiology. Here are a few examples:
- Data analysis: I can help you analyze large sets of data to identify trends, patterns, and correlations that can help you understand the spread of diseases and the factors that influence it. I can also help you identify risk factors, track outbreaks, and monitor the effectiveness of public health interventions.
- Modeling and simulation: I can assist you in building models and simulations that can help you predict the spread of diseases and evaluate the impact of different interventions. This can help you identify the most effective strategies for controlling outbreaks and preventing the spread of diseases.
- Literature review: I can help you perform a comprehensive review of the existing literature on a particular disease or public health issue. This can help you identify knowledge gaps, understand the current state of research, and develop new research questions.
- Natural language processing: I can assist you in extracting meaningful insights from unstructured data sources such as social media, news articles, and medical records. This can help you monitor public sentiment, identify emerging trends, and track disease outbreaks in real time.
- Chatbot: I can be programmed to answer questions related to epidemiology and public health. This can help you provide accurate information to the public and address their concerns and questions in a timely manner.
Please let me know if there's anything specific I can help you with.
It is believed that between a quarter and a third of the world's population is latently infected with Mycobacterium tuberculosis. The importance of latency is reflected in a huge drive by research funding organizations to study the biology and epidemiology of latent tuberculosis infection and to create medications that particularly treat latent infection, with the goal of eradicating tuberculosis globally. Mycobacterium tuberculosis' incubation period lasts around 2-3 weeks following the first infection. The objective is to reduce the incubation period so that the patient may be diagnosed and treated as soon as possible.
Dear All,
I have a question.
Significant heterogeneity is observed between descriptive studies in the meta-analysis for the prevalence or incidence of a given disease in countries around the world. Also, since the amount of prevalence and incidence depend on many factors, so what are the benefits of their pooled means, and what do they represent?
I would be grateful if you please give your feedback.
Best regards,
Dear all,
i am currently working on an SLR for a burden of disease for school work. i am however thinking of changing it into a meta analysis to best capture the epidemiological data (prevalence) and also the costs of management.
Can anyone help me with the best statistical analyses for such a topic and if possible how to go about it. thank you
This is a blur area in the bibliography I study, and the numbers used are mostly rounded up (N=500, N=1000 etc) without any other explanation. What would you suggest?
There is scientific evidence of mRNA and vectorial vaccines' genotoxicity.
mRNA vaccines induce immunodepression increasing vulnerability to communicable and non-communicable diseases ( cancer) and have a high rate of serious adverse effects, including death. Many otherwise healthy young people have died
Scientific evidence is supported by epidemiological data that show an increase in the infection risk from VOC in vaccinated people and in oncologic patients.
Moreover, I suggest reading Christine Cotton's expertise about the mRNA vaccines' unreliability.
In Florida, there was an 83% increase in mortality in vaccinated people.
We proposed on Research gate an International Research Manifesto for the withdrawal of mRNA and vectorial vaccines. if you agree you could sign it for building an international pressure lobby and there is an open discussion on Researchgate about this topic.
A Research Manifesto for anti-COVID-19 mRNA, and vectorial sera withdrawal https://www.researchgate.net/post/A_Research_Manifesto_for_anti-COVID_19_mRNA_and_vectorial_sera_withdrawlhttps://www.worldhealthcommittee.net/a-research-manifesto-against-anti-covid-19-mrna-and-vectorial-vaccines/
Reference on Research Gate
Canada for example, has a population of about 35 million people. Suppose there are 10 million cell phones (probably there are more) at an average cost of about $1,000 (probably the average price is less). So that is an infrastructure of about $10 billion. Plus the cell networks, many billions more. We already have an installed infrastructure that would permit the mass aggregation of data. Now add a cheap plug-in cell phone dongle with free app software paid for by the government for the whole country that can manipulate the dongle and which can be improved. Then have everybody self test, with the app uploading the data. Test everyone in one day. Over and over again. This takes advantage of the expensive but existing cell phone and network infrastructure. Is it possible?
In Mexico, as in other latitudes, the measures against COVID-19 have decreased and the governments and health entities of each country have applied their own criteria as a result of what they know and that their population tends to respond epidemiologically speaking. Do you think that the WHO should make the declaration that the pandemic has ended?
Hello Scholars,
I am an undergraduate at the University of Cross River State, Nigeria currently pursuing a microbiology program. For familiarity and enhanced understanding of the course, I wish to seek recommendations on the virtual/simulation laboratory software that would be very helpful to me and my colleagues. With my interest in research too, I will be pleased if a research simulator is recommended to help widen my understanding of Microbiological research.
Your recommendations would go a long way to significantly contribute to my academic career as well as my colleagues.
Thank you
I am working on a rare case of mesothelioma and I am interested in knowing the epidemiology, especially in African countries
Dear All,
My current field is Epidemiology. Also, I am highly interested in the field of Nutrition Sciences and looking forward to increasing my knowledge in that.
I would be thankful if you could let me know whether there has been any recommendation beyond the relevant reading and collaborating with nutritionists in academic writing.
Kind regards,
Is there any diseases which has high YLL and high YLD, high YLL but low YLD and low YLL and high YLD. Please give me some example and why it happens.
I am collecting data from multiple published epidemiology studies. I want to represent the overall prevalence data by a single value. For example, if prevalence of disease is 30% in one region and 20% in another, how should I calculate the overall prevalence of the disease? Can I take an average [(30+20)/20=25%], or is there another way to collate such data?
Dear researched,
I read a paper from one well known publisher. Paper is about gestational diabetees. At the age 45+ they found 35 cases of diabetes and 90 women without it. They wrote: ''Te incidence of GDM at age≥45years was as high as 38.89%.'' I would suggest 28%? What do you think?
In addition, I have some question. If something increase from 50 to 200, that is 4 times increase?
What about folds? In my opinion, folds are not same as times? The next article stated in abstract: ''neutralizing antibodies were increased by 10.3–28.9 times at 4 weeks after the booster'' and than in results ''eutralizing antibody GMTs then increased during the 4 weeks after the booster dose until day 237 by 28.9, 10.3, and 11.9-fold". Was this written correctly?
This article suggested weighted population density in some epidemiological studies.
Do you know in which type of study weighted is preferable? Should other population characteristics be weighted also? Such as gender ratio, population income... Also, some events, such as infectious disease and healthcare utilization, are strongly related to density.
Many thanks for considering my request.
As part of my fellowship, I want to evaluate the oral health surveillance system as part of my fellowship. I already read CDC's guidelines for evaluating surveillance systems, but I am still confused about how to assess one. Does anyone have examples of work or reviews done for this type of evaluation?
In 1965 English Statistician Sir Bradford Hill gave 9 criteria's to provide epidemiological evidence of a causal relationship between presumed cause and observed effect. The criteria are as follows:
mnemonic- SCST ABCDE
S- Strength of association
C- Consistency
S- Specificity(Most difficult)
T- Temporality(Most important)
A-Analogy
B- Biological Plausibility
C-Coherence
D- Dose- response relationship
E - Experimental evidence
As we know specificity is difficult to ascertain ,So should all the criteria's to be fulfilled before ascertaining causality as compared to simple association?
I am based on path analysis (structural equation modeling). I want to investigate the impact of Sulfur dioxide emissions on mortality.
- When I construct this path (Mortality rate <--- Sulfur dioxide emissions) the coefficient is positive and significant.
- Next, when I add additional path (Sulfur dioxide emissions <--- GDP per capita) the coefficient of Sulfur dioxide emissions on mortality is still positive and significant and the coefficient of GDP per capita on Sulfur dioxide emissions is significantly negative.
- However, when I add the third path (Mortality rate <--- GDP per capita). The coefficients of GDP on mortality and Sulfur dioxide emissions are both significantly negative. However, now the coefficient of Sulfur dioxide emissions on mortality is insignificant now.
Why this coefficient is insignificant now?
I need to know influence of Epidemiology in policy making and also influence of policy in Epidemiology as a discipline.
I read interestingly one article titled “Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016”. In the article, authors performed Frontier analysis. I tried it in R software (Benchmarking, rDEA package) but could not perfectly did well. I only got the efficiency for every country at each year but failed to get the frontier pinpoint. I have examined many books and papers but could not find the answer.
Could anybody know how to perform frontier analysis using data envelopment analysis?
I think MATLAB is preferred over R for this purpose, especially in epidemiology, isn't it?
There is a concept of viral load.
Viral load has been considered in connection with HIV (Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis, 2014, Blaser et al.).
In another context, a 2010 article by several authors, DeVincenzo et al, Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus. Page 1312 of the report mentions “the potential clinical effectiveness derived by achieving a robust reduction in viral load through antiviral compounds."
Is it possible that how much virus there is affects how serious a disease results on being infected by COVID-19? If that were so, then in addition to isolating COVID-19 cases to inhibit transmission, it might be possible to inhibit severity of the disease by reducing viral load.
Is there research on this? If not, should there be?
Some epidemiological researches have complex aim that is answered using many objectives. Upon close look on the objectives, they are often discovered to fit to varying designs models; cross sectional, case-control, quasi experimental etc. Yet, most researchers usually, resolve to adopt the design of the dominant research question/objective while neglecting the other objectives. This has effects even on the sample size calculations and the tests of significance to be conducted later.
For example the significance values for prevalent symptoms in case of COVID-19. Please help.
What statistical test to apply in this case?
What is the prevalence of the symptoms to be compared with to test significance?
I want to know the epidemiology of fractures and their impact on fracture healing, as well as their impact on treatment methods
I want to estimate the incidence of chronic myeloid leukemia in a region from retrospective data (approximately 30 years). Is it possible to do so? and if not how I can exploit my data epidemiologically?
In bifurcation analysis, normal form of Bogdanov-Takens bifurcation is deduced. But I want to know it's biological significance.
Hello to all
About 3 months ago, I asked this question, but I didn't get a comprehensive answer.
Can a person who has had Coronavirus disease (COVID-19) get infected again?
In view of the continuous evolution of science, especially in the field of mathematical epidemiology, and the ideology observed in this direction, I formulated a thesis project proposing a hybrid model broadening the field of understanding of infectious diseases, especially Covid-19. This model is a combination of the well known classical SEIR model and another newly introduced model under experimentation giving more data on the geographical aspect of the said disease needed to enhance the accuracy of the existing epidemiological systems or to build one as needed.
One reason for posting this question is to hope that by following this question it is possible to keep up on developments pertaining to this question.
An article in a health magazine, Stat, by Sharon Begley, Experts envision two scenarios if the new coronavirus isn’t contained, suggests the answer for now is, not sure.
An article in Lancet, Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study, by Prof. Joseph T. Wu, Kathy Leung, and Prof. Gabriel M Leung, remarks in the discussion portion of their paper that `independent self-sustaining human-to-human spread is already present in multiple Chinese cities’ including global transport hubs. This suggests that containing, confining and eliminating COVID-19 as a pervasive and ongoing infectious disease might not be possible.
If infected people do not acquire immunity, that affects calculations of the ongoing spread of COVID-19. For example, if 70% of a population catches COVID-19 and most survive and acquire immunity, then the size of the group that COVID -19 could newly infect would be smaller. In that way, over time, as the number of people who survive the disease increases, the rate of new infections might decline because there would be fewer people without acquired immunity. I wonder what epidemiology says? These issues also affect hopes for a vaccine.
Regardless of what the immunity situation is, it seems to be that there should be a permanent cultural shift away from greetings such as handshakes and kissing.
Dear Researchers
We have launched a set of meta-analysis studies on prevalences of different medical conditions before and after the COVID-19 pandemic, where we just include studies in our meta-analysis that have compared epidemiological data of that disease before and after COVID-19 pandemic.
A manuscript of perforated appendicitis rate before vs. after COVID-19 has been finished and submitted to a journal but many available datasets that are already analyzed need a team to help finish about 10 articles!
some topics are ectopic pregnancy rate, DKA, testicular torsion, depression and psychiatric problems before and after pandemic!
Please Do not hesitate to contact me for getting contributed to this researches.
National Geographic April 5,2020 article is titled: Tiger tests positive for coronavirus at Bronx Zoo, first known case in the world.
If wild animals, including birds, can be a reservoir hosting COVID-19, that may pose additional hurdles to limiting and containing COVID-19.
Are there reports or studies bearing on this issue?
In the current pandemic situation, it is not possible to completely avoid a psychiatric patient carrying COVID-19 or being directly symptomatic. In addition, medical priority is to help anyone. How is your psychiatric clinic prepared for this situation? What is the experience of Italian psychiatrists or psychiatrists from other countries of the world (China, European states?)
COVID-19 infection is currently superior to any mental disorder, but what is your management of an acute psychiatric patient with a positive epidemiological history or clinical symptoms? I am very curious about your opinions, comments and observations.
In a Next Generation Matrix, the dominant eigenvalue (or spectral radius) corresponds to R0 (Diekmann, O., Heesterbeek, J. A., & Roberts, M. G., 2010).
What information then carry the remaining (non-dominant) eigenvalues of this matrix? Can they inform us about other dynamics of an epidemic?
A researchable topics and research ideas in Epidemiology suitable for Doctorate degree Thesis
Have there been any studies?
As a part of my PhD, I conducted a study to assess health inequities in Amaravati capital region of Andhra Pradesh using two composite indices made from health determinants indicators and health outcome indicators.
Health outcome indicators data was available at the sub-district level. The data were interpolated to create a heatmap of the health outcome index. Whereas health determinants data was available at the village level. Thus I created a choropleth map using the health determinants index.
Later interpolated health outcome index map was overlayered on the choropleth map of health outcomes. It highlighted some interesting findings, i.e. areas of concern (Villages). The colour combinations created because of overlaying two layers revealed the areas with poor health outcomes and poor health determinants and areas with poor health outcomes with better determinants.
Kindly check these files and give your valuable opinions. Whether this type of analysis can be used to highlight the areas with health inequities or not? Please comment on the method used and the results obtained in the overlayered map.
What do you think are the most important psychological disorders associated with COVID-19?
1. In risk assessment studies pertaining to pandemic epidemiology, what are the major considerations?
2. COVID-19 has been featured in all fora where major scientific approaches have been adopted. As a high-level risk, its assessment should be holistic, superb, discreet and interdisciplinary. Apart from the risk of transmission to higher populations, health care systems, sustainable human livelihoods, water and ecological issues, are there other factors with links of references?
3. Do you think the expected time set aside for different countries in Europe, America, Asia and Africa is enough to contain the risk?
4. What model of mitigation can afford to painstakingly handle this risk in the environment?
You are free to attend any number of your choice friends.